CARVEDILOL
Portal hypertension
Strength6.25 mg
Formoral.solid
6.25 mg once daily initially, titrate to 12.5 mg once daily as blood pressure allows - long-term
Not a primary-care prescription in children. Paediatric cirrhosis is managed by specialist hepatology.
Carvedilol SmPC (https://www.medicines.org.uk/emc/product/1298/smpc)
NICE 1.3.3 makes carvedilol the first choice for preventing decompensation in clinically significant portal hypertension, ahead of propranolol, because it has fewer side effects and a greater effect on portal vein pressure. Propranolol is the second choice, for when carvedilol is contraindicated.
- If carvedilol is contraindicated, propranolol 40 mg twice daily is the second choice - NICE names both and puts carvedilol first.
- Off-label. NICE recorded in September 2023 that using either drug for the primary prevention of decompensation is outside their licence.
- Start at the low dose and go up slowly. These patients are often already hypotensive, and a beta-blocker that drops the pressure further does harm.
- Contraindicated in asthma, second or third degree heart block, and uncontrolled heart failure. Caution in refractory ascites, where a non-selective beta-blocker may worsen the circulation.
| Egyptian brand | Manufacturer | Indicative price |
|---|---|---|
| VIDILOL 6.25 MG 10 TABS. | MEMPHIS | 3.50 EGP (0.35/unit) |
| CARLOL-V 6.25MG 30 F.C.TAB | AMOUN | 19.50 EGP (0.65/unit) |
| KARVEX 6.25MG 30 TAB. | SIGMA | 19.50 EGP (0.65/unit) |
| CARDILOL 6.25MG 30 TAB. | MARCYRL PHARMACEUTICAL INDUSTRIES (MPI) | 39.00 EGP (1.30/unit) |
| CARVID 6.25MG 20 TAB. | MULTI-APEX | 30.00 EGP (1.50/unit) |
| CARVID 6.25MG 30 TAB. | MULTI-APEX | 45.00 EGP (1.50/unit) |
| DILATROL 6.25MG 30 TAB. | CHEMIPHARM | 48.00 EGP (1.60/unit) |
| CARVIPRESS 6.25MG 20 SCORED TAB. | GLOBAL NAPI PHARMACEUTICALS | 13.00 EGP |